The role of NLRP3 inflammasome in aging and age-related diseases

被引:6
|
作者
Liang, Ruikai [1 ,2 ]
Qi, Xinrui [1 ,3 ]
Cai, Qi [1 ,2 ]
Niu, Liyan [4 ]
Huang, Xi [2 ]
Zhang, Deju [5 ]
Ling, Jitao [1 ]
Wu, Yuting [1 ]
Chen, Yixuan [6 ]
Yang, Pingping [1 ]
Liu, Jianping [1 ]
Zhang, Jing [6 ]
Yu, Peng [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Clin Med Coll 2, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Queen Mary Sch, Nanchang, Peoples R China
[4] Nanchang Univ, Huan Kui Coll, Nanchang, Peoples R China
[5] Univ Hong Kong, Sch Biol Sci, Food & Nutr Sci, Hong Kong, Peoples R China
[6] Nanchang Univ, Affiliated Hosp 2, Dept Anesthesiol, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
NLRP3; inflammasome; Aging; Related diseases; Regulatory mechanisms; Therapeutic strategies; AMYOTROPHIC-LATERAL-SCLEROSIS; C-REACTIVE PROTEIN; CELLULAR SENESCENCE; HEART-FAILURE; GENE-EXPRESSION; ACTIVATION; HYPERTENSION; INHIBITION; MACROPHAGES; ASSOCIATION;
D O I
10.1186/s12979-023-00395-z
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The gradual aging of the global population has led to a surge in age-related diseases, which seriously threaten human health. Researchers are dedicated to understanding and coping with the complexities of aging, constantly uncovering the substances and mechanism related to aging like chronic low-grade inflammation. The NOD-like receptor protein 3 (NLRP3), a key regulator of the innate immune response, recognizes molecular patterns associated with pathogens and injury, initiating an intrinsic inflammatory immune response. Dysfunctional NLRP3 is linked to the onset of related diseases, particularly in the context of aging. Therefore, a profound comprehension of the regulatory mechanisms of the NLRP3 inflammasome in aging-related diseases holds the potential to enhance treatment strategies for these conditions. In this article, we review the significance of the NLRP3 inflammasome in the initiation and progression of diverse aging-related diseases. Furthermore, we explore preventive and therapeutic strategies for aging and related diseases by manipulating the NLRP3 inflammasome, along with its upstream and downstream mechanisms.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Role of the NLRP3 inflammasome in cancer
    Moossavi, Maryam
    Parsamanesh, Negin
    Bahrami, Afsane
    Atkin, Stephen L.
    Sahebkar, Amirhossein
    MOLECULAR CANCER, 2018, 17
  • [42] Role of the NLRP3 Inflammasome in Preeclampsia
    Shirasuna, Koumei
    Karasawa, Tadayoshi
    Takahashi, Masafumi
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [43] The role of the NLRP3 inflammasome in gout
    Kingsbury, Sarah R.
    Conaghan, Philip G.
    McDermott, Michael F.
    JOURNAL OF INFLAMMATION RESEARCH, 2011, 4 : 39 - 49
  • [44] Role of the NLRP3 inflammasome in cancer
    Maryam Moossavi
    Negin Parsamanesh
    Afsane Bahrami
    Stephen L. Atkin
    Amirhossein Sahebkar
    Molecular Cancer, 17
  • [45] The Role of NLRP3 Inflammasome in Pericarditis
    Mauro, Adolfo G.
    Bonaventura, Aldo
    Vecchie, Alessandra
    Mezzaroma, Eleonora
    Carbone, Salvatore
    Narayan, Pratyush
    Potere, Nicola
    Cannata, Antonio
    Paolini, John F.
    Bussani, Rossana
    Montecucco, Fabrizio
    Sinagra, Gianfranco
    Van Tassel, Benjamin W.
    Abbate, Antonio
    Toldo, Stefano
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2021, 6 (02): : 137 - 150
  • [46] Exosomes Regulate NLRP3 Inflammasome in Diseases
    Li, Zhangwang
    Chen, Xinyue
    Tao, Junjie
    Shi, Ao
    Zhang, Jing
    Yu, Peng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [47] NLRP3 inflammasome in cancer and metabolic diseases
    Bhesh Raj Sharma
    Thirumala-Devi Kanneganti
    Nature Immunology, 2021, 22 : 550 - 559
  • [48] Targeting the NLRP3 inflammasome in cardiovascular diseases
    Toldo, Stefano
    Mezzaroma, Eleonora
    Buckley, Leo F.
    Potere, Nicola
    Di Nisio, Marcello
    Biondi-Zoccai, Giuseppe
    Van Tassell, Benjamin W.
    Abbate, Antonio
    PHARMACOLOGY & THERAPEUTICS, 2022, 236
  • [49] Targeting the NLRP3 inflammasome in inflammatory diseases
    Matthew S. J. Mangan
    Edward J. Olhava
    William R. Roush
    H. Martin Seidel
    Gary D. Glick
    Eicke Latz
    Nature Reviews Drug Discovery, 2018, 17 : 588 - 606
  • [50] The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
    Chenyang Yu
    Caihua Zhang
    Zhihui Kuang
    Qiang Zheng
    Inflammation, 2021, 44 : 434 - 449